Efficacy and safety of first-line bevacizumab combined with paclitaxel in 220 patients with metastatic breast cancer: The Hungarian AVAREG observational study

被引：0
作者：
Dank, Magdolna
Budi, Laszlo
Landherr, Laszlo
Piko, Bela
Mangel, Laszlo
Erfan, Jozsef
Cseh, Jozsef
Ruzsa, Agnes
Nagy, Andras
机构：
[1] Semmelweis Univ, H-1085 Budapest, Hungary
[2] BAZ Cty Hosp, Miskolc, Hungary
[3] Uzsoki St Hosp, Budapest, Hungary
[4] Bekes Cty Pandy Kalman Hosp, Gyula, Hungary
[5] Univ Pecs, Fac Med, Pecs, Hungary
[6] Josa Andras Oktata Korhaz, Nyiregyhaza, Hungary
[7] Fejer Cty St George Hosp, Szekesfehervar, Hungary
[8] Zala Cty Hosp, Zalaegerszeg, Hungary
[9] Roche Hungary Ltd, Budaors, Hungary
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12022
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer
    Acuña, LR
    Langhi, M
    Pérez, J
    Acuña, JR
    Machiavelli, M
    Lacava, J
    Vallejo, C
    Romero, A
    Fasce, H
    Ortiz, E
    Grasso, S
    Amato, S
    Rodríguez, R
    Barbieri, M
    Leone, B
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 74 - 81
  • [32] Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA
    Franchi, Matteo
    Barni, Sandro
    Tagliabue, Giovanna
    Ricci, Paolo
    Mazzucco, Walter
    Tumino, Rosario
    Caputo, Antonietta
    Corrao, Giovanni
    Corrao, Giovanni
    Franchi, Matteo
    Barni, Sandro
    Tagliabue, Giovanna
    Fabiano, Sabrina
    Barigelletti, Giulio
    Ricci, Paolo
    Gatti, Lucina
    Mazzucco, Walter
    Cusimano, Rosanna
    Vitale, Francesco
    Tumino, Rosario
    Giurdanella, Maria Concetta
    Rollo, Patrizia Concetta
    Spata, Eugenia
    Caputo, Antonietta
    De Ceglie, Maria Carolina
    ONCOLOGIST, 2019, 24 (03) : 358 - 365
  • [33] Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study
    Lonardi, Sara
    Nasti, Guglielmo
    Fagnani, Daniele
    Gemma, Donatello
    Ciuffreda, Libero
    Granetto, Cristina
    Lucchesi, Sara
    Ballestrero, Alberto
    Biglietto, Maria
    Proserpio, Ilaria
    Bergamo, Francesca
    Proietti, Emanuela
    Tonini, Giuseppe
    Adamo, V
    Aieta, M.
    Alabiso, O.
    Amoroso, D.
    Angelini, F.
    Ardizzoia, A.
    Aschele, C.
    Astorino, M.
    Benasso, M.
    Beretta, G.
    Bonciarelli, C.
    Bonetti, A.
    Brugnatelli, S.
    Cammiluzzi, E.
    Cappuzzo, F.
    Carapezza, M. A.
    Carlomagno, C.
    Cazzaniga, M.
    Ciardiello, F.
    Cinieri, S.
    Comandone, A.
    Crino, L.
    Daniele, B.
    D'Arco, A.
    Ferrari, D.
    Ferrau, F.
    Ficorella, C.
    Fioroni, I
    Francini, G.
    Frassoldati, A.
    Giordano, M.
    Giustini, L.
    Gottardi, O.
    Greco, E.
    Iaffaioli, V. R.
    Lanzillo, M. G.
    Latini, L.
    TUMORI JOURNAL, 2019, 105 (03): : 243 - 252
  • [34] Safety and efficacy of first-line docetaxel-gemcitabine in metastatic breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 168 - 168
  • [35] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    Ozcelik, M.
    Odabas, H.
    Ercelep, O.
    Yuksel, S.
    Mert, A. G.
    Aydin, D.
    Surmeli, H.
    Isik, D.
    Isik, S.
    Oyman, A.
    Ustaalioglu, B. B. Oven
    Aliustaoglu, M.
    Gumus, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (06) : 617 - 624
  • [36] Preliminary results of a randomized phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer
    Hoelzer, K. L.
    Brufsky, A.
    Hainsworth, J.
    Beck, J. T.
    Whorf, R.
    Keaton, M.
    Kroener, J.
    Krill-Jackson, E.
    Hu, S.
    Bromund, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis
    Wang Ming
    Zheng Xiaofeng
    Ruan Xiaojiao
    Ye Bailiang
    Cai Long
    Lin Feizhuan
    Tu Jinfu
    Jiang Feizhao
    Li Shaotang
    CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 538 - 546
  • [38] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    M. Ozcelik
    H. Odabas
    O. Ercelep
    S. Yuksel
    A. G. Mert
    D. Aydin
    H. Surmeli
    D. Isik
    S. Isik
    A. Oyman
    B. B. Oven Ustaalioglu
    M. Aliustaoglu
    M. Gumus
    Clinical and Translational Oncology, 2016, 18 : 617 - 624
  • [39] Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
    Hamilton, Erika
    Kimmick, Gretchen
    Hopkins, Judith
    Marcom, P. Kelly
    Rocha, Gloria
    Welch, Renee
    Broadwater, Gloria
    Blackwell, Kimberly
    CLINICAL BREAST CANCER, 2013, 13 (06) : 416 - 420
  • [40] Efficacy and safety of toripalimab combined with doxorubicin as first-line treatment for metastatic soft tissue sarcomas: an observational study
    Liu, Zhiyong
    Liu, Cuiping
    Yao, Weitao
    Gao, Songtao
    Wang, Jiaqiang
    Zhang, Peng
    Ge, Hong
    ANTI-CANCER DRUGS, 2021, 32 (09) : 962 - 968
12345